Socioepidemiological screening of serologically ineligible blood donors due to Chagas disease for the definition of inconclusive cases
AUTOR(ES)
Ferreira-Silva, Márcia M, Pereira, Gilberto A, Lages-Silva, Eliane, Moraes-Souza, Helio
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2010-09
RESUMO
Epidemiological screening combined with serological tests has become an important tool at blood banks for the characterization of donors with or without Trypanosoma cruzi infection. Thus, the objective of the present study was to describe the sociodemographic and epidemiological characteristics of blood donors with non-negative serology for T. cruzito determine possible risk factors associated with serological ineligibility. Sociodemographic and epidemiological data were collected by analysis of patient histories and interviews. The data were analyzed descriptively using absolute and relative frequencies and odds ratio (OR) evaluation. The frequency of serological ineligibility was 0.28%, with a predominance of inconclusive reactions (52%) and seropositivity among first-time donors (OR = 607), donors older than 30 years (OR = 3.7), females (OR = 1.9), donors from risk areas (OR = 4) and subjects living in rural areas (OR = 1.7). The risk of seropositivity was higher among donors who had contact with the triatomine vector (OR = 11.7) and those with a family history of Chagas disease (OR = 4.8). The results demonstrate the value of detailed clinical-epidemiological screening as an auxiliary tool for serological definition that, together with more specific and more sensitive laboratory methods, will guarantee a higher efficacy in the selection of donors at blood centres.
Documentos Relacionados
- Definition of a diagnostic routine in individuals with inconclusive serology for chagas disease
- Performance of six diagnostic tests to screen for Chagas disease in blood banks and prevalence of Trypanosoma cruzi infection among donors with inconclusive serology screening based on the analysis of epidemiological variables
- Tattoos and transfusion-transmitted disease risk: implications for the screening of blood donors in Brazil
- The value of screening blood donors for antibody to hepatitis B core antigen.
- Polymerase chain reaction and blood culture in blood donors screened by ELISA test for Chagas' disease